Eosinophil Granule Proteins: Form and Function

Experimental and clinical data strongly support a role for the eosinophil in the pathogenesis of asthma, allergic and parasitic diseases, and hypereosinophilic syndromes, in addition to more recently identified immunomodulatory roles in shaping innate host defense, adaptive immunity, tissue repair/remodeling, and maintenance of normal tissue homeostasis. A seminal finding was the dependence of allergic airway inflammation on eosinophil-induced recruitment of Th2-polarized effector T-cells to the lung, providing a missing link between these innate immune effectors (eosinophils) and adaptive T-cell responses. Eosinophils come equipped with preformed enzymatic and nonenzymatic cationic proteins, stored in and selectively secreted from their large secondary (specific) granules. These proteins contribute to the functions of the eosinophil in airway inflammation, tissue damage, and remodeling in the asthmatic diathesis. Studies using eosinophil-deficient mouse models, including eosinophil-derived granule protein double knock-out mice (major basic protein-1/eosinophil peroxidase dual gene deletion) show that eosinophils are required for all major hallmarks of asthma pathophysiology: airway epithelial damage and hyperreactivity, and airway remodeling including smooth muscle hyperplasia and subepithelial fibrosis. Here we review key molecular aspects of these eosinophil-derived granule proteins in terms of structure-function relationships to advance understanding of their roles in eosinophil cell biology, molecular biology, and immunobiology in health and disease.

[1]  Paige Lacy,et al.  Eosinophil activities modulate the immune/inflammatory character of allergic respiratory responses in mice , 2014, Allergy.

[2]  S. Ackerman,et al.  To be, or not to be, an eosinophil: that is the ??? , 2013, Blood.

[3]  James J. Lee,et al.  PHAGOCYTES , GRANULOCYTES , AND MYELOPOIESIS Expression of the secondary granule proteins major basic protein 1 ( MBP-1 ) and eosinophil peroxidase ( EPX ) is required for eosinophilopoiesis in mice , 2013 .

[4]  Marc Torrent,et al.  Two Human Host Defense Ribonucleases against Mycobacteria, the Eosinophil Cationic Protein (RNase 3) and RNase 7 , 2013, Antimicrobial Agents and Chemotherapy.

[5]  H. Simon,et al.  Extracellular DNA traps in allergic, infectious, and autoimmune diseases , 2013, Allergy.

[6]  K. Dyer,et al.  Eosinophils: changing perspectives in health and disease , 2012, Nature Reviews Immunology.

[7]  H. Simon,et al.  Eosinophil extracellular DNA traps: molecular mechanisms and potential roles in disease. , 2012, Current opinion in immunology.

[8]  Ulla-Britt Jönsson,et al.  Eosinophil associated genes in the inflammatory bowel disease 4 region: correlation to inflammatory bowel disease revealed. , 2012, World journal of gastroenterology.

[9]  M. V. Nogués,et al.  Exploring New Biological Functions of Amyloids: Bacteria Cell Agglutination Mediated by Host Protein Aggregation , 2012, PLoS pathogens.

[10]  H. Simon,et al.  Thymic stromal lymphopoietin stimulates the formation of eosinophil extracellular traps , 2012, Allergy.

[11]  D. Fleischer,et al.  The oesophageal string test: a novel, minimally invasive method measures mucosal inflammation in eosinophilic oesophagitis , 2012, Gut.

[12]  J. Douglass,et al.  Galectin-10, a Potential Biomarker of Eosinophilic Airway Inflammation , 2012, PloS one.

[13]  M. V. Nogués,et al.  Structural determinants of the eosinophil cationic protein antimicrobial activity , 2012, Biological chemistry.

[14]  A. Neunkirchner,et al.  Naturally occurring regulatory T cells: markers, mechanisms, and manipulation , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  James J. Lee,et al.  Eosinophils Preserve Parasitic Nematode Larvae by Regulating Local Immunity , 2012, The Journal of Immunology.

[16]  E. Boix,et al.  Refining the eosinophil cationic protein antibacterial pharmacophore by rational structure minimization. , 2011, Journal of medicinal chemistry.

[17]  H. Simon,et al.  Eosinophil and neutrophil extracellular DNA traps in human allergic asthmatic airways. , 2011, The Journal of allergy and clinical immunology.

[18]  E. Boix,et al.  Mapping the eosinophil cationic protein antimicrobial activity by chemical and enzymatic cleavage. , 2011, Biochimie.

[19]  H. Simon,et al.  Eosinophil extracellular DNA traps in skin diseases. , 2011, The Journal of allergy and clinical immunology.

[20]  C. Janson,et al.  Associations of ECP (eosinophil cationic protein)-gene polymorphisms to allergy, asthma, smoke habits and lung function in two Estonian and Swedish sub cohorts of the ECRHS II study , 2010, BMC pulmonary medicine.

[21]  C. Halldén,et al.  CLC– a novel susceptibility gene for allergic rhinitis? , 2010, Allergy.

[22]  Parameswaran Nair,et al.  Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. , 2009, The New England journal of medicine.

[23]  A. Engström,et al.  The Coding ECP 434(G>C) Gene Polymorphism Determines the Cytotoxicity of ECP but Has Minor Effects on Fibroblast-Mediated Gel Contraction and No Effect on RNase Activity1 , 2009, The Journal of Immunology.

[24]  James J. Lee,et al.  Eosinophil Deficiency Compromises Parasite Survival in Chronic Nematode Infection1 , 2009, The Journal of Immunology.

[25]  P. Venge,et al.  Eosinophil Cationic Protein (ECP) Is Processed during Secretion , 2009 .

[26]  M. Schirle,et al.  Post-translational Tyrosine Nitration of Eosinophil Granule Toxins Mediated by Eosinophil Peroxidase* , 2008, Journal of Biological Chemistry.

[27]  A. Straumann,et al.  Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense , 2008, Nature Medicine.

[28]  James J. Lee,et al.  Major basic protein-1 promotes fibrosis of dystrophic muscle and attenuates the cellular immune response in muscular dystrophy. , 2008, Human molecular genetics.

[29]  S. Phipps,et al.  Eosinophils: Biological Properties and Role in Health and Disease , 2008, Clinical and Experimental Allergy.

[30]  J. Parkin,et al.  Treatment of patients with the hypereosinophilic syndrome with mepolizumab. , 2008, The New England journal of medicine.

[31]  H. Rosenberg,et al.  Eosinophil-derived neurotoxin acts as an alarmin to activate the TLR2–MyD88 signal pathway in dendritic cells and enhances Th2 immune responses , 2008, The Journal of experimental medicine.

[32]  P. Venge,et al.  The 434(G>C) polymorphism within the coding sequence of Eosinophil Cationic Protein (ECP) correlates with the natural course of Schistosoma mansoni infection. , 2007, International journal for parasitology.

[33]  Christian Becker,et al.  Human CD4+CD25+ regulatory T cells: proteome analysis identifies galectin-10 as a novel marker essential for their anergy and suppressive function. , 2007, Blood.

[34]  A. Engström,et al.  The functional heterogeneity of eosinophil cationic protein is determined by a gene polymorphism and post‐translational modifications , 2007, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[35]  Shawn A. Mahmud,et al.  Thiocyanate-Dependent Induction of Endothelial Cell Adhesion Molecule Expression by Phagocyte Peroxidases: A Novel HOSCN-Specific Oxidant Mechanism to Amplify Inflammation1 , 2006, The Journal of Immunology.

[36]  G. Gleich,et al.  Eosinophil-Derived Cationic Proteins Activate the Synthesis of Remodeling Factors by Airway Epithelial Cells1 , 2006, The Journal of Immunology.

[37]  M. Saeftel,et al.  Lack of Eosinophil Peroxidase or Major Basic Protein Impairs Defense against Murine Filarial Infection , 2006, Infection and Immunity.

[38]  C. J. Barnes,et al.  Maintenance and polarization of human TH2 central memory T cells by thymic stromal lymphopoietin-activated dendritic cells. , 2006, Immunity.

[39]  C Tagesson,et al.  Comparative proteomics of nasal fluid in seasonal allergic rhinitis. , 2006, Journal of proteome research.

[40]  J. Geng,et al.  The principal eosinophil peroxidase product, HOSCN, is a uniquely potent phagocyte oxidant inducer of endothelial cell tissue factor activity: a potential mechanism for thrombosis in eosinophilic inflammatory states. , 2006, Blood.

[41]  G. J. Swaminathan,et al.  Eosinophil-granule major basic protein, a C-type lectin, binds heparin. , 2005, Biochemistry.

[42]  C. Wennerås,et al.  Human eosinophils selectively recognize and become activated by bacteria belonging to different taxonomic groups. , 2005, Microbes and infection.

[43]  S. Kingsmore,et al.  Human Ribonuclease A Superfamily Members, Eosinophil-Derived Neurotoxin and Pancreatic Ribonuclease, Induce Dendritic Cell Maturation and Activation1 , 2004, The Journal of Immunology.

[44]  S. Orkin,et al.  A Critical Role for Eosinophils in Allergic Airways Remodeling , 2004, Science.

[45]  E. Lenkiewicz,et al.  Defining a Link with Asthma in Mice Congenitally Deficient in Eosinophils , 2004, Science.

[46]  F. Levi-Schaffer,et al.  Eosinophil major basic protein: first identified natural heparanase-inhibiting protein. , 2004, The Journal of allergy and clinical immunology.

[47]  Paige Lacy,et al.  Divergence of Mechanisms Regulating Respiratory Burst in Blood and Sputum Eosinophils and Neutrophils from Atopic Subjects1 , 2003, The Journal of Immunology.

[48]  H. R. Evans,et al.  The crystal structure of eosinophil cationic protein in complex with 2',5'-ADP at 2.0 A resolution reveals the details of the ribonucleolytic active site. , 2002, Biochemistry.

[49]  Wei Xu,et al.  Immobilized Lactoferrin Is a Stimulus for Eosinophil Activation1 , 2002, The Journal of Immunology.

[50]  Ulla-Britt Jönsson,et al.  Polymorphism of the eosinophil cationic protein‐gene is related to the expression of allergic symptoms , 2002, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[51]  G. J. Swaminathan,et al.  Charcot-Leyden Crystal Protein (Galectin-10) Is Not a Dual Function Galectin with Lysophospholipase Activity but Binds a Lysophospholipase Inhibitor in a Novel Structural Fashion* , 2002, The Journal of Biological Chemistry.

[52]  H. Rosenberg,et al.  Eosinophils, eosinophil ribonucleases, and their role in host defense against respiratory virus pathogens , 2001, Journal of leukocyte biology.

[53]  S. Hazen,et al.  Extensive Eosinophil Degranulation and Peroxidase-Mediated Oxidation of Airway Proteins Do Not Occur in a Mouse Ovalbumin-Challenge Model of Pulmonary Inflammation1 , 2001, The Journal of Immunology.

[54]  G. J. Swaminathan,et al.  Crystal Structure of the Eosinophil Major Basic Protein at 1.8 Å , 2001, Journal of Biological Chemistry.

[55]  E. Boix,et al.  Identification and characterization of human eosinophil cationic protein by an epitope‐specific antibody , 2001, Journal of leukocyte biology.

[56]  G. J. Swaminathan,et al.  Mapping the Ribonucleolytic Active Site of Eosinophil-derived Neurotoxin (EDN) , 2001, The Journal of Biological Chemistry.

[57]  S.,et al.  Biochemical Characterization of Human Eosinophil Charcot-Leyden Crystal Protein ( Lysophospholipase ) * , 2001 .

[58]  James J. Lee,et al.  Eosinophil Major Basic Protein-1 Does Not Contribute to Allergen-Induced Airway Pathologies in Mouse Models of Asthma1 , 2000, The Journal of Immunology.

[59]  Jianzhi Zhang,et al.  Evolution of the rodent eosinophil-associated RNase gene family by rapid gene sorting and positive selection. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[60]  E. Boix,et al.  Crystal structure of eosinophil cationic protein at 2.4 A resolution. , 1999, Biochemistry.

[61]  A. Fryer,et al.  Ozone-induced hyperresponsiveness and blockade of M2 muscarinic receptors by eosinophil major basic protein. , 1999, Journal of applied physiology.

[62]  Acharya,et al.  Selective Recognition of Mannose by the Human Eosinophil Charcot-Leyden Crystal Protein (Galectin-10): A Crystallographic Study at 1.8 Å Resolution. , 1999, Biochemistry.

[63]  E. Boix,et al.  Kinetic and Product Distribution Analysis of Human Eosinophil Cationic Protein Indicates a Subsite Arrangement That Favors Exonuclease-type Activity* , 1999, The Journal of Biological Chemistry.

[64]  Stephen Naylor,et al.  A Novel and Highly Divergent Homolog of Human Eosinophil Granule Major Basic Protein* , 1999, The Journal of Biological Chemistry.

[65]  K. Dyer,et al.  Eosinophil cationic protein/RNase 3 is another RNase A-family ribonuclease with direct antiviral activity. , 1998, Nucleic acids research.

[66]  H. Kita,et al.  Localization of eosinophil‐derived neurotoxin and eosinophil cationic protein in neutrophilic leukocytes , 1998, Journal of leukocyte biology.

[67]  K. Dyer,et al.  Recombinant human eosinophil-derived neurotoxin/RNase 2 functions as an effective antiviral agent against respiratory syncytial virus. , 1998, The Journal of infectious diseases.

[68]  A. Fryer,et al.  Pretreatment with antibody to eosinophil major basic protein prevents hyperresponsiveness by protecting neuronal M2 muscarinic receptors in antigen-challenged guinea pigs. , 1997, The Journal of clinical investigation.

[69]  K. Dyer,et al.  The genomic structure of the human Charcot-Leyden crystal protein gene is analogous to those of the galectin genes. , 1997, Genomics.

[70]  E. Olson,et al.  Two highly homologous ribonuclease genes expressed in mouse eosinophils identify a larger subgroup of the mammalian ribonuclease superfamily. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[71]  K. Acharya,et al.  Crystal structure of human Charcot-Leyden crystal protein, an eosinophil lysophospholipase, identifies it as a new member of the carbohydrate-binding family of galectins. , 1995, Structure.

[72]  J F Vliegenthart,et al.  New type of linkage between a carbohydrate and a protein: C-glycosylation of a specific tryptophan residue in human RNase Us. , 1994, Biochemistry.

[73]  D. Newton,et al.  Expression and characterization of recombinant human eosinophil-derived neurotoxin and eosinophil-derived neurotoxin-anti-transferrin receptor sFv. , 1994, The Journal of biological chemistry.

[74]  C. Oxvig,et al.  Localization of disulfide bridges and free sulfhydryl groups in human eosinophil granule major basic protein , 1994, FEBS letters.

[75]  G. Gleich,et al.  Human eosinophil major basic protein is an endogenous allosteric antagonist at the inhibitory muscarinic M2 receptor. , 1993, The Journal of clinical investigation.

[76]  D. Tenen,et al.  Molecular cloning and characterization of human eosinophil Charcot-Leyden crystal protein (lysophospholipase). Similarities to IgE binding proteins and the S-type animal lectin superfamily. , 1993, Journal of immunology.

[77]  G. Gleich,et al.  The biology of the eosinophilic leukocyte. , 1993, Annual review of medicine.

[78]  H. Kita,et al.  Eosinophil granule proteins in peripheral blood granulocytes , 1992, Journal of leukocyte biology.

[79]  A. Fryer,et al.  Function of pulmonary M2 muscarinic receptors in antigen-challenged guinea pigs is restored by heparin and poly-L-glutamate. , 1992, The Journal of clinical investigation.

[80]  D. Loegering,et al.  Eosinophil-derived neurotoxin and human liver ribonuclease. Identity of structure and linkage of neurotoxicity to nuclease activity. , 1992, The Journal of biological chemistry.

[81]  A. Dvorak,et al.  Charcot‐Leyden crystal protein in the degranulation and recovery of activated basophils , 1992, Journal of leukocyte biology.

[82]  G. Gleich,et al.  Human eosinophil major basic protein induces airway constriction and airway hyperresponsiveness in primates. , 1991, The Journal of clinical investigation.

[83]  M. Heise,et al.  Structure and chromosome localization of the human eosinophil-derived neurotoxin and eosinophil cationic protein genes: evidence for intronless coding sequences in the ribonuclease gene superfamily. , 1990, Genomics.

[84]  R. L. Barker,et al.  In vitro killing of microfilariae of Brugia pahangi and Brugia malayi by eosinophil granule proteins. , 1990, Journal of immunology.

[85]  L. Patthy Homology of cytotoxic protein of eosinophilic leukocytes with IgE receptor Fcϵ RII: Implications for its structure and function , 1989 .

[86]  D. Tenen,et al.  Human eosinophil cationic protein. Molecular cloning of a cytotoxin and helminthotoxin with ribonuclease activity , 1989, The Journal of experimental medicine.

[87]  D. Tenen,et al.  Molecular cloning of the human eosinophil-derived neurotoxin: a member of the ribonuclease gene family. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[88]  R. L. Barker,et al.  Comparative toxicity of purified human eosinophil granule proteins for newborn larvae of Trichinella spiralis. , 1987, The Journal of parasitology.

[89]  D. Loegering,et al.  Biochemical and functional similarities between human eosinophil-derived neurotoxin and eosinophil cationic protein: homology with ribonuclease. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[90]  H. Haugen,et al.  Differences between basophils and mast cells: failure to detect Charcot-Leyden crystal protein (lysophospholipase) and eosinophil granule major basic protein in human mast cells. , 1986, Journal of immunology.

[91]  J. Harley,et al.  Distinctive cationic proteins of the human eosinophil granule: major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin. , 1983, Journal of immunology.

[92]  T. Habermann,et al.  Localization of eosinophil granule major basic protein in human basophils , 1983, The Journal of experimental medicine.

[93]  R. Dahl,et al.  The Gordon phenomenon induced by the eosinophil cationic protein and eosinophil protein X. , 1982, The Journal of allergy and clinical immunology.

[94]  W. Henderson,et al.  Eosinophil peroxidase-mediated inactivation of leukotrienes B4, C4, and D4. , 1982, Journal of immunology.

[95]  G. Gleich,et al.  Formation of Charcot-Leyden crystals by human basophils , 1982, The Journal of experimental medicine.

[96]  R. Locksley,et al.  Role for endogenous and acquired peroxidase in the toxoplasmacidal activity of murine and human mononuclear phagocytes. , 1982, The Journal of clinical investigation.

[97]  A. Capron,et al.  Activation of rat and human eosinophils by soluble factor(s) released by Schistosoma mansoni Schistosomula. , 1982, Cellular immunology.

[98]  W. Henderson,et al.  Binding of eosinophil peroxidase to mast cell granules with retention of peroxidatic activity. , 1980, Journal of immunology.